Randomised trial of two versus three doses of human papillomavirus (HPV) vaccine in India
Not Applicable
Completed
- Conditions
- Cervical precancerous lesions and cervical cancerCancerCervical cancer
- Registration Number
- ISRCTN98283094
- Lead Sponsor
- International Agency for Research on Cancer (IARC) (France)
- Brief Summary
2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26652797 results 2018 Results article in http://www.ncbi.nlm.nih.gov/pubmed/29551226 early results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34634254/ (added 12/10/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 16000
Inclusion Criteria
1. Apparently healthy, ambulant, unmarried girls aged 10 - 18 years and with intact uterus
2. Resident in the villages chosen for the study
Exclusion Criteria
Girls with any severe and/or debilitating illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method